Endometrial Cancer
Showing NaN - NaN of 38
Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))
Completed
- Ovarian Cancer
- +7 more
- Enapotamab vedotin (HuMax-AXL-ADC)
-
Phoenix, Arizona
- +40 more
Dec 12, 2022
Biliary Tract Cancer (BTC), Colorectal Cancer (CRC), Endometrial Cancer Trial in Belgium, United Kingdom, United States
Completed
- Biliary Tract Cancer (BTC)
- +5 more
- INCB001158
- +6 more
-
Birmingham, Alabama
- +9 more
Dec 22, 2022
Endometrial Cancer Trial in Worldwide (Selinexor, Matching for selinexor)
Active, not recruiting
- Endometrial Cancer
- Selinexor
- Matching placebo for selinexor
-
Tucson, Arizona
- +104 more
Aug 11, 2022
Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan
Not yet recruiting
- Endometrial Cancer
- +4 more
- Datopotamab deruxtecan (Dato-DXd)
- +8 more
-
Los Angeles, California
- +52 more
Aug 3, 2022
Endometrial Cancer Trial in Worldwide (Atezolizumab, Placebos, Paclitaxel)
Active, not recruiting
- Endometrial Cancer
- Atezolizumab
- +3 more
-
Adelaide, Australia
- +96 more
Jan 31, 2022
Endometrial Cancer Trial in Canada (Conventional Fractionation, Hypofractionation)
Recruiting
- Endometrial Cancer
- Conventional Fractionation
- Hypofractionation
-
Barrie, Ontario, Canada
- +4 more
Oct 22, 2021
Endometrial Cancer Trial in United Kingdom (BMN 673)
Withdrawn
- Endometrial Cancer
- BMN 673
-
Brighton, East Sussex, United Kingdom
- +15 more
Aug 5, 2021
Cancer Diagnosis and Treatment on Everyday Life
Active, not recruiting
- Breast Cancer Female
- +17 more
-
Aberystwyth, United Kingdom
- +110 more
Mar 16, 2021
Endometrial Cancer, Endometrial Tumors, Endometrial Hyperplasia Trial in London (3D Ultrasound)
Unknown status
- Endometrial Cancer
- +2 more
- 3D Ultrasound
-
London, United KingdomQueen Charlotte and Hammersmith Hospital
Feb 11, 2021
Endometrial Cancer, Endometrial Tumors, Endometrial Hyperplasia Trial in London (Ultrasound guided biopsy)
Unknown status
- Endometrial Cancer
- +3 more
- Ultrasound guided biopsy
-
London, United KingdomQueen Charlotte and Hammersmith Hospital
Feb 11, 2021
Can Staging Magnetic Resonance Imaging Features Prognosticate
Recruiting
- Endometrial Cancer
- Endometrial Neoplasms
- Radiomics: Analysis of textural features of imaging (MRI and Ultrasound)
-
London, United KingdomQueen Charlotte and Hammersmith Hospital
Feb 11, 2021
Rectal Cancer, Ovarian Cancer, Endometrial Cancer Trial in London (Sonablate 500 (High Intensity Focused Ultrasound (HIFU)))
Withdrawn
- Rectal Cancer
- +4 more
- Sonablate 500 (High Intensity Focused Ultrasound (HIFU))
-
London, England, United KingdomImperial College Healthcare NHS Trust (Hammersmith Hospital)
Nov 18, 2020
Endometrial Tumors, Endometrial Cancer, Endometrial Hyperplasia Trial in London (iKnife i.e. Rapid Evaporative Ionisation Mass
Completed
- Endometrial Neoplasms
- +3 more
- iKnife i.e. Rapid Evaporative Ionisation Mass Spectrometry
-
London, United KingdomQueen Charlotte and Hammersmith Hospital
Jun 26, 2020
Women With Suspected Endometrial Cancer
Completed
- Endometrial Cancer
- +5 more
-
London, United KingdomQueen Charlotte and Hammersmith Hospital
Jul 13, 2020
Endometrial Cancer Trial in Australia, Canada, United States (radiation therapy)
Completed
- Endometrial Cancer
- radiation therapy
-
Duluth, Minnesota
- +24 more
Apr 2, 2020
MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in Detection of Lymph
Completed
- Surgically Staged Endometrial and Cervical Carcinoma
- +5 more
- Diffusion-weighted MRI
- +2 more
-
Birmingham, United Kingdom
- +6 more
Feb 12, 2020
Endometrial Cancer Trial in London (Abdominal surgery, Lymphadenectomy)
Terminated
- Endometrial Cancer
- Abdominal surgery
- Lymphadenectomy
-
London, Greater London, United KingdomUniversity College Hospital
Sep 26, 2019
Rectal Cancer, Rectal Tumors, Pelvic Cancer Trial in London (High Intensity Focused Ultrasound)
Recruiting
- Rectal Cancer
- +4 more
- High Intensity Focused Ultrasound
-
London, United KingdomImperial College London
Aug 13, 2019